"Cell Movement" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.
| Descriptor ID |
D002465
|
| MeSH Number(s) |
G04.198 G07.568.500.180
|
| Concept/Terms |
Cell Movement- Cell Movement
- Cell Movements
- Movements, Cell
- Movement, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Movement".
Below are MeSH descriptors whose meaning is more specific than "Cell Movement".
This graph shows the total number of publications written about "Cell Movement" by people in this website by year, and whether "Cell Movement" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 9 | 10 |
| 1996 | 1 | 8 | 9 |
| 1997 | 5 | 13 | 18 |
| 1998 | 4 | 6 | 10 |
| 1999 | 6 | 8 | 14 |
| 2000 | 8 | 15 | 23 |
| 2001 | 6 | 30 | 36 |
| 2002 | 8 | 20 | 28 |
| 2003 | 13 | 30 | 43 |
| 2004 | 17 | 29 | 46 |
| 2005 | 15 | 33 | 48 |
| 2006 | 13 | 40 | 53 |
| 2007 | 18 | 43 | 61 |
| 2008 | 22 | 46 | 68 |
| 2009 | 25 | 61 | 86 |
| 2010 | 33 | 60 | 93 |
| 2011 | 17 | 46 | 63 |
| 2012 | 22 | 57 | 79 |
| 2013 | 22 | 68 | 90 |
| 2014 | 19 | 68 | 87 |
| 2015 | 17 | 51 | 68 |
| 2016 | 25 | 63 | 88 |
| 2017 | 10 | 54 | 64 |
| 2018 | 8 | 51 | 59 |
| 2019 | 4 | 35 | 39 |
| 2020 | 5 | 42 | 47 |
| 2021 | 7 | 42 | 49 |
| 2022 | 2 | 17 | 19 |
| 2023 | 0 | 8 | 8 |
| 2024 | 5 | 12 | 17 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Movement" by people in Profiles.
-
Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B. Hereditas. 2024 Dec 21; 161(1):53.
-
COL10A1 Facilitates Prostate Cancer Progression by Interacting With INHBA to Activate the PI3K/AKT Pathway. J Cell Mol Med. 2024 Dec; 28(23):e70249.
-
Dissecting the novel molecular interactions of solute carrier family 4 member 4 (SLC4A4) for prostate cancer (PCa) progression. Sci Rep. 2024 11 25; 14(1):29133.
-
Evidence that CRISPR-Cas9 Y537S-mutant expressing breast cancer cells activate Yes-associated protein 1 to driving the conversion of normal fibroblasts into cancer-associated fibroblasts. Cell Commun Signal. 2024 Nov 14; 22(1):545.
-
Investigation of the a9-nicotinic receptor single nucleotide polymorphisms induced oncogenic properties and molecular mechanisms in breast cancer. Hum Mol Genet. 2024 11 08; 33(22):1948-1965.
-
IFN-treated macrophage-derived exosomes prevents HBV-HCC migration and invasion via regulating miR-106b-3p/PCGF3/PI3K/AKT signaling axis. Front Cell Infect Microbiol. 2024; 14:1421195.
-
A compartmentalized microfluidic platform to investigate immune cells cross-talk in rheumatoid arthritis. Biofabrication. 2024 Oct 24; 17(1).
-
QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age-related macular degeneration. Br J Pharmacol. 2025 Feb; 182(4):951-968.
-
MicroRNA-1307-3p contributes to breast cancer progression through PRM2. Thorac Cancer. 2024 Nov; 15(32):2298-2308.
-
Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models. Clin Cancer Res. 2024 Oct 01; 30(19):4434-4449.